Neonatal Bilirubin: Age in Hours and the Selected Guideline Belong Beside the Result

Quick Medical Calculator · Reading label 26 September 2026 · 4 min read

Retrospective study sequence, not publication date

"Bilirubin 210 on day two" is not enough information for a neonatal handover. It leaves the unit, exact postnatal age, measurement method, gestational age and applicable guidance unresolved. Adding a calculator-generated label cannot recover information that was never entered.

A useful record keeps the laboratory observation separate from the clinical comparison. First establish what was measured and when. Then establish which guideline and patient-specific context govern its interpretation. A threshold is not an intrinsic property of the laboratory number.

Two Clocks, Two Different Questions

Postnatal age describes elapsed time since birth. Gestational age at birth describes maturity. They must remain separate. "36 hours old" does not tell the receiving team whether the infant was born at 34, 37 or 40 weeks.

The 2022 AAP guideline addresses newborn infants born at 35 or more weeks' gestation. Its implementation FAQ explains that gestational age and additional neurotoxicity risk factors affect selection of the appropriate threshold resource. The presence of a gestational-age field in a calculator does not prove that it selects the curve for the user.

NICE CG98 also uses postnatal age in hours and distinguishes measurement circumstances. NICE and AAP should not be combined into an improvised hybrid pathway. Document which applicable guideline the responsible neonatal team is following rather than choosing whichever comparison looks more reassuring.

Fictional Timeline: Replace "Day Two" With an Interval

This original teaching example intentionally stops short of a threshold decision.

• Birth: Monday at 22:40, with the date and local time zone recorded in the fictional source note.
• Sample collection: Wednesday at 10:10, using the same time zone.
• Laboratory release: Wednesday at 11:00.
• Reported result: total serum bilirubin 210 micromol/L.
• Gestational age, additional risk assessment and previous phototherapy history: not provided in the handover.

The sample was collected 35 hours 30 minutes, or 35.5 hours, after birth. The report was released at 36 hours 20 minutes, or approximately 36.33 hours. Those ages describe different events. The collection age belongs with the concentration; the release time helps reconstruct communication and subsequent care.

The calculation does not establish whether 210 micromol/L is above a treatment threshold for this infant. No threshold has been supplied and the clinical context is incomplete. The correct educational conclusion is "comparison not established", not "normal", "low risk" or "safe to wait". Clinical concerns should be assessed without waiting for this documentation exercise to be completed.

What the Local Calculator Actually Does

The neonatal bilirubin tool works in AAP 2022 threshold-comparison mode, not as an automatic curve lookup. It requires externally obtained phototherapy and exchange thresholds and confirmation that both have been checked for the exact age, gestation and risk context. It compares a total serum bilirubin with those supplied values and also derives an escalation-of-care band from the entered exchange threshold. That derived band is equally dependent on correct source selection; it is not independently verified clinical advice.

This design makes the origin of the thresholds especially important. A numerically plausible entry can still come from the wrong infant, age or guideline. The software cannot discover that mistake simply by checking whether the fields are complete. Do not enter a transcutaneous result as though it were a total serum measurement or relabel a NICE threshold as AAP-derived.

An Original Bilirubin Handover Resource

Keep four short blocks together:

Measurement: analyte, value, unit, serum or transcutaneous method, collection date/time and exact age at collection.

Infant context: gestational age at birth and the relevant clinical risk information actually assessed. Mark unknown information as unknown; do not turn a missing answer into an absent risk factor.

Comparison provenance: guideline, version, source used for the threshold, who verified it and the age/risk selection used. If the source cannot be identified, preserve that as an unresolved comparison.

Trajectory and responsibility: previous measurements with their own timestamps, relevant treatment history, current clinical concerns and the clinician/team responsible for the next assessment. Do not copy a previous comparison forward without checking its context.

These blocks are an original communication aid, not a substitute chart or a schedule for testing. They contain no treatment curves, numerical intervention instructions or discharge rule. Their purpose is to prevent a concentration from becoming detached from the baby and the circumstances in which it was obtained.

Retrospective educational reading plan: Day 22 of 50, labelled 2026-09-26. This is a study-sequence label, not a historical publication or clinical-review date. The publication date above records the actual release.